On July 29, 2011, the U.S. Securities and Exchange Commission’s Division of Investment Management (the “Division”) extended temporary no-action assurance that the Division would not recommend enforcement action under Section 17(f) of the Investment Company Act of 1940 against any registered investment company (a “Fund”) if the Fund or its custodian places and maintains cash and/or certain securities in the custody of CME or a CME clearing member for the purpose of meeting CME’s or a clearing member’s margin requirements for certain interest rate swap contracts and credit default swap contracts that are cleared by CME (the “Existing No-Action Letters”).
The no-action relief provided in the Existing No-Action Letters expired on December 31, 2011. However, the Division has provided CME with verbal no-action assurance extending that relief, pending further review of CME’s recently-submitted request for further no-action relief.
Questions regarding this Advisory Notice may be directed to the following individuals:
Mike Kobida (312-454-8961)
Tim Doar (312-930-3162)
Tim Maher (312-930-2730)
CME Group is the world's leading and most diverse derivatives marketplace. The company is comprised of four Designated Contract Markets (DCMs). Further information on each exchange's rules and product listings can be found by clicking on the links to CME, CBOT, NYMEX and COMEX.